Clinical Trials · NCT01223937

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients

Name: Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Desmopressin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Ferring Pharmaceuticals
Enrollment: 268
Start date: Nov 2010
Locations: 45 sites, United States, Canada
Primary endpoint: Change From Baseline in Mean Number of Nocturnal Voids Averaged Over a 3-Month Period

View Desmopressin compound reference